CHARGED ALPHATMFrontier AI stock research

THRM · NasdaqGS

Gentherm Incorporated

Auto Parts · United States

USD 36.35-3.5% daily changeQuote 2026-09-18 · USD
Market cap (USD)
US$1.12B
Trailing P/E
42.27x
Forward P/E
11.15x
Quarterly revenue growth
11.0%
Trailing net margin
1.7%
Indicated dividend yield

Snapshot 2026-09-20 · Latest financial period 2026-06-30 · Yahoo Finance. Quotes may be delayed; reporting periods can differ.

Next earnings: 2026-10-22 (provider estimate, not issuer-confirmed).

Company background

Gentherm Incorporated designs, develops, manufactures, and sells thermal management and pneumatic comfort technologies in the United States, China, Germany, Czech Republic, South Korea, Mexico, Slovakia, Romania, Japan, United Kingdom and internationally. It operates in two segments, Automotive and Medical. The company offers climate comfort systems, including seat heaters, blowers, and thermoelectric devices for variable temperature climate control seats and steering wheel heaters to provide thermal comfort to automobile passengers; integrated electronic components, such as electronic control units; pneumatic lumbar and massage comfort solutions comprising lumbar support, side bolster adjustment, multi-contour seats and massage systems; and other climate and comfort systems, including neck and shoulder conditioners, and climate control systems for door panels and armrests. It also provides automotive cable technology, such as ready-made individual cables and ready-to-install cable networks used to connect components to power sources; battery performance solutions consist of cell connecting devices and battery cable technologies used for various types of batteries and thermal management products; valve systems for brake and engine systems, and fuel management; and electronic and software systems include electronic control units for climate and comfort systems, and electronic control units for memory seat modules and other devices. In addition, the company offers patient temperature management systems under the Blanketrol and Astotherm brands for hyper-hypothermia therapy in intensive care, normothermia in surgical procedures, and additional warming/cooling therapies. It serves light vehicle original equipment manufacturers and tier 1, and medical industry. Gentherm Incorporated was formerly known as Amerigon Incorporated and changed its name to Gentherm Incorporated in September 2012. The company was incorporated in 1991 and is headquartered in Northville, Michigan.

Company website

Q2 2026

Go beyond the headline.

Gentherm Stock: It CRUSHED Earnings and Popped 26% — So Why We Say HOLD (THRM Q2 2026)

Published 2026-07-24

Comparable businesses

THRM peer comparison

Same business group first, then company size. Preferred market cap: 0.5–2x; extended range: one-third–3x. Outside that range, industry benchmarks are labeled separately and excluded from peer medians.

Comparison stocks

Market metrics · missing or inapplicable values shown as —
MetricTHRMGentherm IncorporatedSnapshot 2026-09-20Financial period: 2026-06-30QSQuantumScape CorporationSnapshot 2026-09-20Financial period: 2026-06-30ECXECARX Holdings Inc.Snapshot 2026-09-20Financial period: 2026-06-30Peer medianSimilar-size peers only
Market capMarket value, converted to USDUS$1.12BUS$3.09BUS$400.85MUS$1.75Bn=2
Forward P/EProvider forward earnings estimate11.15x13.60x
EV / EBITDAEnterprise value / trailing EBITDA8.48x66.37x
Revenue growthLatest quarter vs prior-year quarter11.0%47.5%
Operating marginLatest reported quarter7.1%0.0%-2.8%-1.4%n=2
Free cash flow yieldTrailing cash flow / market cap7.5%-4.6%
Net debt / EBITDANet debt / trailing EBITDA0.77x37.07x
Debt / equityTotal debt / positive book equity0.45x0.06x
Trailing P/ETrailing twelve-month earnings42.27x
Price / bookPrice / positive book equity per share1.54x2.97x
EV / salesEnterprise value / trailing revenue0.78x1.01x
Earnings growthLatest quarter vs prior-year quarter798.1%
Gross marginTrailing twelve months24.0%0.0%20.9%10.4%n=2
Net marginTrailing twelve months1.7%0.0%-2.3%-1.1%n=2
Return on equityProvider trailing return; positive equity only3.7%-39.1%
Free cash flow marginTrailing free cash flow / revenue5.3%
Dividend yieldIndicated annual dividend / price
Earnings payoutProvider trailing dividend payout0.0%0.0%0.0%0.0%n=2
Current ratioCurrent assets / current liabilities2.06x18.42x0.72x9.57xn=2
BetaProvider historical market sensitivity1.342.690.991.84n=2

Choose a comparison stock

Search covered companies, or search all listed stocks.

Comparison methodology & limitations

Reviewed operating groups override broad sector classifications. Other companies are matched only within a sufficiently specific provider industry. Business mix, geography and accounting standards can still differ. Market caps are converted to USD using exchange rates captured during the snapshot refresh. Financial ratios that would mix currencies are omitted. Snapshots must be at most 14 days old and no more than seven days apart for automatic selection.

Peer medians require at least two valid similar-size peers for each metric. Negative earnings, nonpositive equity, missing data and irrelevant bank ratios are not presented as attractive valuations. A higher or lower number is not automatically a better investment. Financial statement periods are not calendar-aligned across companies.

Reported performance

Financial trends

Reporting period
Financial history
Chart style
Comparison stocks

Financial statements load separately from the research page.

Market context

Valuation & price history

Adjusted closing price

Price history

Price history loads separately.

Earnings-multiple scenario

Illustrative price = your earnings-per-share assumption × your P/E assumption. This is not a price target or a complete valuation model.

Starting assumptions, when available, use provider forward estimates as of 2026-09-20. Negative earnings require a different valuation method. This calculation omits balance-sheet, dilution and execution risks.

THE RESEARCH RECORD

Research history for THRM

All available reporting periods
Q2 20262026-07-24

Reported figures

Verify material figures against company filings. Market data and AI-assisted analysis may contain errors.